Patents by Inventor Nicholas P. Plotnikoff

Nicholas P. Plotnikoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR INDUCING SUSTAINED IMMUNE RESPONSE
    Publication number: 20140024588
    Abstract: A method for promoting a sustained increased level of T-cell production in immunocompromised subjects in which method enkephalin peptides are administered according to an intermittent dose schedule. In particular, the method involves treatment of immunocompromised patients which includes the administration of enkephalin, either alone or in conjunction with other therapies, in an initial dosage regimen, with periodic booster dosages of enkephalin as necessary to maintain sustained immune system response.
    Type: Application
    Filed: October 3, 2013
    Publication date: January 23, 2014
    Applicant: TNI BIOTECH, INC.
    Inventor: NICHOLAS P. PLOTNIKOFF
  • Methods for inducing sustained immune response
    Patent number: 8633150
    Abstract: A method for promoting a sustained increased level of T-cell production in immunocompromised subjects in which method enkephalin peptides are administered according to an intermittent dose schedule. In particular, the method involves treatment of immunocompromised patients which includes the administration of enkephalin, either alone or in conjunction with other therapies, in an initial dosage regimen, with periodic booster dosages of enkephalin as necessary to maintain sustained immune system response.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: January 21, 2014
    Assignee: TNI Biotech, Inc.
    Inventor: Nicholas P. Plotnikoff
  • Methods for inducing sustained immune response
    Publication number: 20030148942
    Abstract: A method for promoting a sustained increased level of T-cell production in immunocompromised subjects in which method enkephalin peptides are administered according to an intermittent dose schedule. In particular, the method involves treatment of immunocompromised patients which includes the administration of enkephalin, either alone or in conjunction with other therapies, in an initial dosage regimen, with periodic booster dosages of enkephalin as necessary to maintain sustained immune system response.
    Type: Application
    Filed: May 16, 2002
    Publication date: August 7, 2003
    Inventor: Nicholas P. Plotnikoff
  • Process for using endogenous enkephalins and endorphins to inhibit growth of tumerous cells
    Patent number: 4801614
    Abstract: A process for the therapeutic treatment of cancer patients involving stimulation and promotion of the natural immune system (both T cell and NK cell activity) resisting and inhibiting tumorous growth (cancer) as well as resisting infections (viral, bacterial and fungal) by administering an effective dosage (e.g., 0.25 mg per kilogram of body weight to as low as about 10.sup.-14 mg/kg) of an endogenous endorphin (e.g., leucine-enkephalin and methionine-enkephalin).
    Type: Grant
    Filed: October 1, 1987
    Date of Patent: January 31, 1989
    Assignee: TNI Pharmaceuticals, Inc.
    Inventor: Nicholas P. Plotnikoff
  • Process for using endogenous enkephalins and endorphins to stimulate the immune system of patients with aids
    Patent number: 4757049
    Abstract: A process for the therapeutic treatment of AIDS (acquired immune deficiency syndrome) involving stimulation and promotion of the natural immune system (both T cell and NK cell activity) resisting and inhibiting tumorous growth (cancer) as well as resisting infections (viral, bacterial and fungal) by administering an effective dosage (e.g., 0.25 mg per kilogram of body weight to as low as about 10.sup.-4 mg/kg) of an endogenous endorphin (e.g., leucine-enkephalin and methionine-enkephalin).
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: July 12, 1988
    Assignee: TNI Pharmaceuticals, Inc.
    Inventor: Nicholas P. Plotnikoff
  • Process for using endogenous enkephalins and endorphins to stimulate the immune system
    Patent number: 4537878
    Abstract: A process of stimulating and promoting the natural immune system (T cells and NK cells) resisting and inhibiting the growth of tumorous cells as well as resisting infections (virus bacteria, and fungi) is disclosed. Endogenous endorphins are disclosed as the agent for stimulating the immune system.
    Type: Grant
    Filed: April 6, 1984
    Date of Patent: August 27, 1985
    Assignee: TNI Pharmaceuticals, Inc.
    Inventor: Nicholas P. Plotnikoff